25 XP   0   0   10

BALAXI PHARMACEUTICALS LIMITED
Buy, Hold or Sell?

Let's analyse BALAXI PHARMACEUTICALS LIMITED together

PenkeI guess you are interested in BALAXI PHARMACEUTICALS LIMITED. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BALAXI PHARMACEUTICALS LIMITED. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BALAXI PHARMACEUTICALS LIMITED

I send you an email if I find something interesting about BALAXI PHARMACEUTICALS LIMITED.

Quick analysis of BALAXI PHARMACEUTICALS LIMITED (30 sec.)










What can you expect buying and holding a share of BALAXI PHARMACEUTICALS LIMITED? (30 sec.)

How much money do you get?

How much money do you get?
INR0.02
When do you have the money?
1 year
How often do you get paid?
66.7%

What is your share worth?

Current worth
INR180.66
Expected worth in 1 year
INR450.62
How sure are you?
88.9%

+ What do you gain per year?

Total Gains per Share
INR271.94
Return On Investment
47.3%

For what price can you sell your share?

Current Price per Share
INR574.75
Expected price per share
INR458.00 - INR665.00
How sure are you?
50%

1. Valuation of BALAXI PHARMACEUTICALS LIMITED (5 min.)




Live pricePrice per Share (EOD)

INR574.75

Intrinsic Value Per Share

INR-90.17 - INR138.66

Total Value Per Share

INR90.48 - INR319.32

2. Growth of BALAXI PHARMACEUTICALS LIMITED (5 min.)




Is BALAXI PHARMACEUTICALS LIMITED growing?

Current yearPrevious yearGrowGrow %
How rich?$21.9m$13.5m$8.3m38.1%

How much money is BALAXI PHARMACEUTICALS LIMITED making?

Current yearPrevious yearGrowGrow %
Making money$5.5m$5.7m-$203.4k-3.7%
Net Profit Margin13.7%17.1%--

How much money comes from the company's main activities?

3. Financial Health of BALAXI PHARMACEUTICALS LIMITED (5 min.)




4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#306 / 393

Most Revenue
#262 / 393

Most Profit
#187 / 393

What can you expect buying and holding a share of BALAXI PHARMACEUTICALS LIMITED? (5 min.)

Welcome investor! BALAXI PHARMACEUTICALS LIMITED's management wants to use your money to grow the business. In return you get a share of BALAXI PHARMACEUTICALS LIMITED.

What can you expect buying and holding a share of BALAXI PHARMACEUTICALS LIMITED?

First you should know what it really means to hold a share of BALAXI PHARMACEUTICALS LIMITED. And how you can make/lose money.

Speculation

The Price per Share of BALAXI PHARMACEUTICALS LIMITED is INR574.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BALAXI PHARMACEUTICALS LIMITED.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BALAXI PHARMACEUTICALS LIMITED, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR180.66. Based on the TTM, the Book Value Change Per Share is INR67.49 per quarter. Based on the YOY, the Book Value Change Per Share is INR48.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.49 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BALAXI PHARMACEUTICALS LIMITED.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.540.1%0.540.1%0.570.1%0.350.1%0.190.0%
Usd Book Value Change Per Share0.810.1%0.810.1%0.580.1%0.420.1%0.240.0%
Usd Dividend Per Share0.010.0%0.010.0%0.010.0%0.010.0%0.000.0%
Usd Total Gains Per Share0.820.1%0.820.1%0.580.1%0.430.1%0.240.0%
Usd Price Per Share6.36-6.36-4.22-3.64-2.08-
Price to Earnings Ratio11.68-11.68-7.38-9.56--4.08-
Price-to-Total Gains Ratio7.80-7.80-7.22-8.42-9.22-
Price to Book Ratio2.94-2.94-3.11-3.88-16.20-
Price-to-Total Gains Ratio7.80-7.80-7.22-8.42-9.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.897
Number of shares144
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.810.42
Usd Total Gains Per Share0.820.43
Gains per Quarter (144 shares)117.4861.41
Gains per Year (144 shares)469.91245.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
134674603243236
279339306485482
310140014009728728
4141866187012971974
517233323401512131220
620279928101814561466
724326632802116991712
827373237502419411958
931419942202721842204
1034466546903024272450

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.03.00.066.7%6.03.00.066.7%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.02.00.077.8%7.02.00.077.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%6.00.03.066.7%6.00.03.066.7%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.01.00.088.9%8.01.00.088.9%

Fundamentals of BALAXI PHARMACEUTICALS LIMITED

About BALAXI PHARMACEUTICALS LIMITED

  • Other

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BALAXI PHARMACEUTICALS LIMITED.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BALAXI PHARMACEUTICALS LIMITED earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare BALAXI PHARMACEUTICALS LIMITED to the Other industry mean.
  • A Net Profit Margin of 13.7% means that ₹0.14 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 13.7%. The company is making a huge profit. +2
  • The TTM is 13.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ13.7%TTM13.7%0.0%
TTM13.7%YOY17.1%-3.4%
TTM13.7%5Y15.0%-1.3%
5Y15.0%10Y13.5%+1.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7%4.5%+9.2%
TTM13.7%5.5%+8.2%
YOY17.1%6.8%+10.3%
5Y15.0%6.0%+9.0%
10Y13.5%6.1%+7.4%
1.1.2. Return on Assets

Shows how efficient BALAXI PHARMACEUTICALS LIMITED is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BALAXI PHARMACEUTICALS LIMITED to the Other industry mean.
  • 19.2% Return on Assets means that BALAXI PHARMACEUTICALS LIMITED generated ₹0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 19.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 19.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.2%TTM19.2%0.0%
TTM19.2%YOY27.0%-7.8%
TTM19.2%5Y26.7%-7.5%
5Y26.7%10Y12.1%+14.6%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ19.2%1.0%+18.2%
TTM19.2%1.1%+18.1%
YOY27.0%1.5%+25.5%
5Y26.7%1.3%+25.4%
10Y12.1%1.4%+10.7%
1.1.3. Return on Equity

Shows how efficient BALAXI PHARMACEUTICALS LIMITED is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BALAXI PHARMACEUTICALS LIMITED to the Other industry mean.
  • 25.1% Return on Equity means BALAXI PHARMACEUTICALS LIMITED generated ₹0.25 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 25.1%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 25.1%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ25.1%TTM25.1%0.0%
TTM25.1%YOY42.1%-17.0%
TTM25.1%5Y40.8%-15.6%
5Y40.8%10Y20.2%+20.6%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ25.1%3.1%+22.0%
TTM25.1%3.3%+21.8%
YOY42.1%5.0%+37.1%
5Y40.8%3.9%+36.9%
10Y20.2%3.9%+16.3%

1.2. Operating Efficiency of BALAXI PHARMACEUTICALS LIMITED.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BALAXI PHARMACEUTICALS LIMITED is operating .

  • Measures how much profit BALAXI PHARMACEUTICALS LIMITED makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BALAXI PHARMACEUTICALS LIMITED to the Other industry mean.
  • An Operating Margin of 17.1% means the company generated ₹0.17  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 17.1%. The company is operating efficient. +1
  • The TTM is 17.1%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ17.1%TTM17.1%0.0%
TTM17.1%YOY19.6%-2.5%
TTM17.1%5Y18.6%-1.6%
5Y18.6%10Y22.8%-4.2%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ17.1%10.9%+6.2%
TTM17.1%9.5%+7.6%
YOY19.6%8.9%+10.7%
5Y18.6%6.0%+12.6%
10Y22.8%7.3%+15.5%
1.2.2. Operating Ratio

Measures how efficient BALAXI PHARMACEUTICALS LIMITED is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Other industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are ₹0.84 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 0.837. The company is less efficient in keeping operating costs low.
  • The TTM is 0.837. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.837TTM0.8370.000
TTM0.837YOY0.820+0.017
TTM0.8375Y0.844-0.007
5Y0.84410Y0.801+0.043
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8371.258-0.421
TTM0.8371.260-0.423
YOY0.8201.215-0.395
5Y0.8441.257-0.413
10Y0.8011.358-0.557

1.3. Liquidity of BALAXI PHARMACEUTICALS LIMITED.

1.3. Liquidity
1.3.1. Current Ratio

Measures if BALAXI PHARMACEUTICALS LIMITED is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Other industry mean).
  • A Current Ratio of 3.64 means the company has ₹3.64 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 3.642. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.642. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.642TTM3.6420.000
TTM3.642YOY2.229+1.413
TTM3.6425Y3.009+0.633
5Y3.00910Y4.486-1.476
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6421.437+2.205
TTM3.6421.507+2.135
YOY2.2291.531+0.698
5Y3.0091.478+1.531
10Y4.4861.478+3.008
1.3.2. Quick Ratio

Measures if BALAXI PHARMACEUTICALS LIMITED is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BALAXI PHARMACEUTICALS LIMITED to the Other industry mean.
  • A Quick Ratio of 1.57 means the company can pay off ₹1.57 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 1.568. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.568. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.568TTM1.5680.000
TTM1.568YOY0.671+0.897
TTM1.5685Y2.107-0.540
5Y2.10710Y8.599-6.491
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5680.552+1.016
TTM1.5680.604+0.964
YOY0.6710.603+0.068
5Y2.1070.608+1.499
10Y8.5990.603+7.996

1.4. Solvency of BALAXI PHARMACEUTICALS LIMITED.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BALAXI PHARMACEUTICALS LIMITED assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BALAXI PHARMACEUTICALS LIMITED to Other industry mean.
  • A Debt to Asset Ratio of 0.24 means that BALAXI PHARMACEUTICALS LIMITED assets are financed with 23.7% credit (debt) and the remaining percentage (100% - 23.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 0.237. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.237. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.237TTM0.2370.000
TTM0.237YOY0.359-0.122
TTM0.2375Y0.319-0.082
5Y0.31910Y0.222+0.097
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2370.531-0.294
TTM0.2370.527-0.290
YOY0.3590.545-0.186
5Y0.3190.559-0.240
10Y0.2220.570-0.348
1.4.2. Debt to Equity Ratio

Measures if BALAXI PHARMACEUTICALS LIMITED is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BALAXI PHARMACEUTICALS LIMITED to the Other industry mean.
  • A Debt to Equity ratio of 31.1% means that company has ₹0.31 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The MRQ is 0.311. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.311. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.311TTM0.3110.000
TTM0.311YOY0.559-0.249
TTM0.3115Y0.487-0.177
5Y0.48710Y0.321+0.166
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3111.082-0.771
TTM0.3111.074-0.763
YOY0.5591.166-0.607
5Y0.4871.294-0.807
10Y0.3211.460-1.139

2. Market Valuation of BALAXI PHARMACEUTICALS LIMITED

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings BALAXI PHARMACEUTICALS LIMITED generates.

  • Above 15 is considered overpriced but always compare BALAXI PHARMACEUTICALS LIMITED to the Other industry mean.
  • A PE ratio of 11.68 means the investor is paying ₹11.68 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The EOD is 12.659. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.681. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.681. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.659MRQ11.681+0.978
MRQ11.681TTM11.6810.000
TTM11.681YOY7.378+4.303
TTM11.6815Y9.561+2.120
5Y9.56110Y-4.083+13.644
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD12.65913.755-1.096
MRQ11.68110.764+0.917
TTM11.68110.593+1.088
YOY7.37811.234-3.856
5Y9.56111.224-1.663
10Y-4.08312.409-16.492
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The EOD is -65.340. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -60.292. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -60.292. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-65.340MRQ-60.292-5.048
MRQ-60.292TTM-60.2920.000
TTM-60.292YOY51.704-111.997
TTM-60.2925Y-45.112-15.180
5Y-45.11210Y-29.944-15.169
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-65.3404.570-69.910
MRQ-60.2924.168-64.460
TTM-60.2925.228-65.520
YOY51.7041.587+50.117
5Y-45.1121.673-46.785
10Y-29.9443.531-33.475
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BALAXI PHARMACEUTICALS LIMITED is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Other industry mean).
  • A PB ratio of 2.94 means the investor is paying ₹2.94 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of BALAXI PHARMACEUTICALS LIMITED:

  • The EOD is 3.181. Based on the equity, the company is fair priced.
  • The MRQ is 2.936. Based on the equity, the company is underpriced. +1
  • The TTM is 2.936. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.181MRQ2.936+0.246
MRQ2.936TTM2.9360.000
TTM2.936YOY3.107-0.171
TTM2.9365Y3.880-0.945
5Y3.88010Y16.197-12.316
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD3.1811.715+1.466
MRQ2.9361.357+1.579
TTM2.9361.354+1.582
YOY3.1071.444+1.663
5Y3.8801.486+2.394
10Y16.1971.604+14.593
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BALAXI PHARMACEUTICALS LIMITED compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--67.49267.4920%48.184+40%35.108+92%20.073+236%
Book Value Per Share--180.656180.6560%113.164+60%81.454+122%46.706+287%
Current Ratio--3.6423.6420%2.229+63%3.009+21%4.486-19%
Debt To Asset Ratio--0.2370.2370%0.359-34%0.319-26%0.222+7%
Debt To Equity Ratio--0.3110.3110%0.559-44%0.487-36%0.321-3%
Dividend Per Share--0.4920.4920%0.498-1%0.430+14%0.309+59%
Eps--45.40445.4040%47.658-5%29.156+56%15.861+186%
Free Cash Flow Per Share---8.796-8.7960%6.800-229%-5.693-35%-3.744-57%
Free Cash Flow To Equity Per Share--16.40616.4060%6.637+147%16.762-2%16.083+2%
Gross Profit Margin--0.9820.9820%0.979+0%0.9870%0.994-1%
Intrinsic Value_10Y_max--138.660--------
Intrinsic Value_10Y_min---90.172--------
Intrinsic Value_1Y_max--1.810--------
Intrinsic Value_1Y_min---6.603--------
Intrinsic Value_3Y_max--14.649--------
Intrinsic Value_3Y_min---22.063--------
Intrinsic Value_5Y_max--38.591--------
Intrinsic Value_5Y_min---39.844--------
Market Cap--5368786085.0005368786085.0000%3516000000.000+53%2960373437.800+81%1659936354.333+223%
Net Profit Margin--0.1370.1370%0.171-20%0.150-9%0.135+2%
Operating Margin--0.1710.1710%0.196-13%0.186-8%0.228-25%
Operating Ratio--0.8370.8370%0.820+2%0.844-1%0.801+5%
Pb Ratio3.181+8%2.9362.9360%3.107-6%3.880-24%16.197-82%
Pe Ratio12.659+8%11.68111.6810%7.378+58%9.561+22%-4.083+135%
Price Per Share574.750+8%530.350530.3500%351.600+51%303.690+75%173.744+205%
Price To Free Cash Flow Ratio-65.340-8%-60.292-60.2920%51.704-217%-45.112-25%-29.944-50%
Price To Total Gains Ratio8.454+8%7.8017.8010%7.222+8%8.419-7%9.223-15%
Quick Ratio--1.5681.5680%0.671+134%2.107-26%8.599-82%
Return On Assets--0.1920.1920%0.270-29%0.267-28%0.121+58%
Return On Equity--0.2510.2510%0.421-40%0.408-38%0.202+24%
Total Gains Per Share--67.98467.9840%48.683+40%35.539+91%20.382+234%
Usd Book Value--21945576.00021945576.0000%13579692.000+62%9414965.760+133%5283569.969+315%
Usd Book Value Change Per Share--0.8100.8100%0.578+40%0.421+92%0.241+236%
Usd Book Value Per Share--2.1682.1680%1.358+60%0.977+122%0.560+287%
Usd Dividend Per Share--0.0060.0060%0.006-1%0.005+14%0.004+59%
Usd Eps--0.5450.5450%0.572-5%0.350+56%0.190+186%
Usd Free Cash Flow---1068552.000-1068552.0000%816024.000-231%-489940.800-54%-293408.805-73%
Usd Free Cash Flow Per Share---0.106-0.1060%0.082-229%-0.068-35%-0.045-57%
Usd Free Cash Flow To Equity Per Share--0.1970.1970%0.080+147%0.201-2%0.193+2%
Usd Market Cap--64425433.02064425433.0200%42192000.000+53%35524481.254+81%19919236.252+223%
Usd Price Per Share6.897+8%6.3646.3640%4.219+51%3.644+75%2.085+205%
Usd Profit--5515500.0005515500.0000%5718936.000-4%3355851.120+64%1843503.719+199%
Usd Revenue--40371912.00040371912.0000%33526536.000+20%21753151.440+86%12079174.771+234%
Usd Total Gains Per Share--0.8160.8160%0.584+40%0.426+91%0.245+234%
 EOD+3 -3MRQTTM+0 -0YOY+21 -155Y+22 -1410Y+24 -12

3.2. Fundamental Score

Let's check the fundamental score of BALAXI PHARMACEUTICALS LIMITED based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.659
Price to Book Ratio (EOD)Between0-13.181
Net Profit Margin (MRQ)Greater than00.137
Operating Margin (MRQ)Greater than00.171
Quick Ratio (MRQ)Greater than11.568
Current Ratio (MRQ)Greater than13.642
Debt to Asset Ratio (MRQ)Less than10.237
Debt to Equity Ratio (MRQ)Less than10.311
Return on Equity (MRQ)Greater than0.150.251
Return on Assets (MRQ)Greater than0.050.192
Total9/10 (90.0%)

3.3. Technical Score

Let's check the technical score of BALAXI PHARMACEUTICALS LIMITED based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.863
Ma 20Greater thanMa 50546.418
Ma 50Greater thanMa 100553.539
Ma 100Greater thanMa 200492.769
OpenGreater thanClose582.900
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets2,396,690
Total Liabilities567,892
Total Stockholder Equity1,828,798
 As reported
Total Liabilities 567,892
Total Stockholder Equity+ 1,828,798
Total Assets = 2,396,690

Assets

Total Assets2,396,690
Total Current Assets1,935,109
Long-term Assets461,581
Total Current Assets
Cash And Cash Equivalents 282,168
Net Receivables 550,730
Inventory 1,050,233
Other Current Assets 51,978
Total Current Assets  (as reported)1,935,109
Total Current Assets  (calculated)1,935,109
+/-0
Long-term Assets
Property Plant Equipment 190,155
Goodwill 252,235
Intangible Assets 9,095
Other Assets 19,191
Long-term Assets  (as reported)461,581
Long-term Assets  (calculated)470,676
+/- 9,095

Liabilities & Shareholders' Equity

Total Current Liabilities531,333
Long-term Liabilities36,559
Total Stockholder Equity1,828,798
Total Current Liabilities
Short-term Debt 107,510
Short Long Term Debt 107,510
Accounts payable 364,803
Other Current Liabilities 8,454
Total Current Liabilities  (as reported)531,333
Total Current Liabilities  (calculated)588,277
+/- 56,944
Long-term Liabilities
Long term Debt Total 25,555
Other Liabilities 11,004
Long-term Liabilities  (as reported)36,559
Long-term Liabilities  (calculated)36,559
+/-0
Total Stockholder Equity
Common Stock101,813
Retained Earnings 1,431,094
Accumulated Other Comprehensive Income 103,430
Other Stockholders Equity 192,461
Total Stockholder Equity (as reported)1,828,798
Total Stockholder Equity (calculated)1,828,798
+/-0
Other
Capital Stock101,813
Cash and Short Term Investments 282,168
Common Stock Shares Outstanding 10,123
Current Deferred Revenue50,566
Liabilities and Stockholders Equity 2,396,690
Net Debt -149,103
Net Invested Capital 1,945,005
Net Tangible Assets 1,576,563
Net Working Capital 1,403,776
Property Plant and Equipment Gross 190,155
Short Long Term Debt Total 133,065



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-31
> Total Assets 
368
357
25,766
16,867
61,078
359,711
996,796
1,764,706
2,396,690
2,396,6901,764,706996,796359,71161,07816,86725,766357368
   > Total Current Assets 
26
26
25,380
16,460
57,766
348,613
937,707
1,410,031
1,935,109
1,935,1091,410,031937,707348,61357,76616,46025,3802626
       Cash And Cash Equivalents 
2
1
23,038
16,460
1,330
40,007
16,690
71,929
282,168
282,16871,92916,69040,0071,33016,46023,03812
       Short-term Investments 
0
1
0
0
0
0
0
1,843
0
01,8430000010
       Net Receivables 
0
1,838
0
0
46,924
299,094
784,305
350,789
550,730
550,730350,789784,305299,09446,924001,8380
       Other Current Assets 
3
3
2,342
0
1,191
1,191
533
277
51,978
51,9782775331,1911,19102,34233
   > Long-term Assets 
342
331
385
406
3,312
11,098
59,102
354,675
461,581
461,581354,67559,10211,0983,312406385331342
       Property Plant Equipment 
0
0
21
94
114
1,866
11,686
52,024
190,155
190,15552,02411,6861,866114942100
       Goodwill 
0
0
0
0
0
12,791
12,791
233,020
252,235
252,235233,02012,79112,79100000
       Long Term Investments 
0
32,737
15
11
0
0
0
0
0
00000111532,7370
       Intangible Assets 
0
9
0
0
0
0
8,247
8,247
9,095
9,0958,2478,247000090
       Other Assets 
0
358
302
302
3,199
9,233
-13
16,685
19,191
19,19116,685-139,2333,1993023023580
> Total Liabilities 
46
42
2,174
1,321
25,873
82,251
346,998
633,065
567,892
567,892633,065346,99882,25125,8731,3212,1744246
   > Total Current Liabilities 
46
42
2,174
1,321
25,873
82,218
346,927
632,676
531,333
531,333632,676346,92782,21825,8731,3212,1744246
       Short-term Debt 
0
20
-5
0
0
36,592
36,592
36,381
107,510
107,51036,38136,59236,59200-5200
       Short Long Term Debt 
0
25
-5
0
0
0
36,592
36,381
107,510
107,51036,38136,592000-5250
       Accounts payable 
13
0
3
944
20,801
48,467
220,578
491,145
364,803
364,803491,145220,57848,46720,8019443013
       Other Current Liabilities 
33
22
2,177
377
5,072
33,751
1,283
105,150
8,454
8,454105,1501,28333,7515,0723772,1772233
   > Long-term Liabilities 
0
20
0
944
0
33
71
389
36,559
36,559389713309440200
       Long term Debt Total 
0
0
0
0
0
0
0
0
25,555
25,55500000000
       Other Liabilities 
0
0
0
0
0
33
71
389
11,004
11,004389713300000
> Total Stockholder Equity
322
315
23,592
15,546
35,205
277,460
649,798
1,131,641
1,828,798
1,828,7981,131,641649,798277,46035,20515,54623,592315322
   Common Stock
304
304
30,400
30,400
30,400
100,000
100,000
100,000
101,813
101,813100,000100,000100,00030,40030,40030,400304304
   Retained Earnings 
2
-5
-8,439
-16,485
3,175
64,469
436,807
918,650
1,431,094
1,431,094918,650436,80764,4693,175-16,485-8,439-52
   Capital Surplus 
0
0
0
0
0
0
112,530
112,530
0
0112,530112,530000000
   Treasury Stock000000000
   Other Stockholders Equity 
16
16
1,631
1,631
1,631
112,530
112,530
112,530
192,461
192,461112,530112,530112,5301,6311,6311,6311616



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue3,364,326
Cost of Revenue-2,024,156
Gross Profit1,340,1701,340,170
 
Operating Income (+$)
Gross Profit1,340,170
Operating Expense-792,316
Operating Income574,223547,854
 
Operating Expense (+$)
Research Development0
Selling General Administrative485,252
Selling And Marketing Expenses8,407
Operating Expense792,316493,659
 
Net Interest Income (+$)
Interest Income5,000
Interest Expense-5,000
Other Finance Cost-5,000
Net Interest Income-5,000
 
Pretax Income (+$)
Operating Income574,223
Net Interest Income-5,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)569,223579,223
EBIT - interestExpense = 569,223
569,223
464,625
Interest Expense5,000
Earnings Before Interest and Taxes (EBIT)574,223574,223
Earnings Before Interest and Taxes (EBITDA)591,748
 
After tax Income (+$)
Income Before Tax569,223
Tax Provision-109,598
Net Income From Continuing Ops459,625459,625
Net Income459,625
Net Income Applicable To Common Shares459,625
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,816,472
Total Other Income/Expenses Net-5,0005,000
 

Technical Analysis of BALAXI PHARMACEUTICALS LIMITED
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BALAXI PHARMACEUTICALS LIMITED. The general trend of BALAXI PHARMACEUTICALS LIMITED is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BALAXI PHARMACEUTICALS LIMITED's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BALAXI PHARMACEUTICALS LIMITED.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 597.95 < 655.00 < 665.00.

The bearish price targets are: 535.80 > 462.40 > 458.00.

Tweet this
BALAXI PHARMACEUTICALS LIMITED Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BALAXI PHARMACEUTICALS LIMITED. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BALAXI PHARMACEUTICALS LIMITED Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BALAXI PHARMACEUTICALS LIMITED. The current macd is 12.69.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the BALAXI PHARMACEUTICALS LIMITED price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for BALAXI PHARMACEUTICALS LIMITED. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the BALAXI PHARMACEUTICALS LIMITED price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BALAXI PHARMACEUTICALS LIMITED Daily Moving Average Convergence/Divergence (MACD) ChartBALAXI PHARMACEUTICALS LIMITED Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BALAXI PHARMACEUTICALS LIMITED. The current adx is 17.53.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy BALAXI PHARMACEUTICALS LIMITED shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
BALAXI PHARMACEUTICALS LIMITED Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BALAXI PHARMACEUTICALS LIMITED. The current sar is 557.75.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
BALAXI PHARMACEUTICALS LIMITED Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BALAXI PHARMACEUTICALS LIMITED. The current rsi is 56.86. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
BALAXI PHARMACEUTICALS LIMITED Daily Relative Strength Index (RSI) ChartBALAXI PHARMACEUTICALS LIMITED Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BALAXI PHARMACEUTICALS LIMITED. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the BALAXI PHARMACEUTICALS LIMITED price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
BALAXI PHARMACEUTICALS LIMITED Daily Stochastic Oscillator ChartBALAXI PHARMACEUTICALS LIMITED Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BALAXI PHARMACEUTICALS LIMITED. The current cci is 57.55.

BALAXI PHARMACEUTICALS LIMITED Daily Commodity Channel Index (CCI) ChartBALAXI PHARMACEUTICALS LIMITED Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BALAXI PHARMACEUTICALS LIMITED. The current cmo is 16.92.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BALAXI PHARMACEUTICALS LIMITED Daily Chande Momentum Oscillator (CMO) ChartBALAXI PHARMACEUTICALS LIMITED Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BALAXI PHARMACEUTICALS LIMITED. The current willr is -20.13888889.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that BALAXI PHARMACEUTICALS LIMITED is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BALAXI PHARMACEUTICALS LIMITED Daily Williams %R ChartBALAXI PHARMACEUTICALS LIMITED Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BALAXI PHARMACEUTICALS LIMITED.

BALAXI PHARMACEUTICALS LIMITED Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BALAXI PHARMACEUTICALS LIMITED. The current atr is 29.37.

BALAXI PHARMACEUTICALS LIMITED Daily Average True Range (ATR) ChartBALAXI PHARMACEUTICALS LIMITED Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BALAXI PHARMACEUTICALS LIMITED. The current obv is 656,804.

BALAXI PHARMACEUTICALS LIMITED Daily On-Balance Volume (OBV) ChartBALAXI PHARMACEUTICALS LIMITED Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BALAXI PHARMACEUTICALS LIMITED. The current mfi is 72.14.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
BALAXI PHARMACEUTICALS LIMITED Daily Money Flow Index (MFI) ChartBALAXI PHARMACEUTICALS LIMITED Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BALAXI PHARMACEUTICALS LIMITED.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

BALAXI PHARMACEUTICALS LIMITED Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BALAXI PHARMACEUTICALS LIMITED based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.863
Ma 20Greater thanMa 50546.418
Ma 50Greater thanMa 100553.539
Ma 100Greater thanMa 200492.769
OpenGreater thanClose582.900
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of BALAXI PHARMACEUTICALS LIMITED with someone you think should read this too:
  • Are you bullish or bearish on BALAXI PHARMACEUTICALS LIMITED? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BALAXI PHARMACEUTICALS LIMITED? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BALAXI PHARMACEUTICALS LIMITED

I send you an email if I find something interesting about BALAXI PHARMACEUTICALS LIMITED.


Comments

How you think about this?

Leave a comment

Stay informed about BALAXI PHARMACEUTICALS LIMITED.

Receive notifications about BALAXI PHARMACEUTICALS LIMITED in your mailbox!